USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Merz Pharma Gmbh & Co. Kgaa

USPTO PatentsView assignee record - 68 granted patents across 23 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Compiled by PlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

12.8

Avg claims per patent

+19%

5-year filing velocity

The verdict

Merz holds 68 US patents across 23 technology areas, rank #5,094 of 50,000 tracked assignees.

#5,094
of 50,000 US assignees by volume: Top 23%
by Innovation Score (45.5/100): 12.8
avg claims per patent: +19%
filing velocity, last 5 yrs

Portfolio overview

Merz Pharma Gmbh & Co. Kgaa has been granted 68 US utility patents between 2015 and 2025, placing Merz Pharma Gmbh & Co. Kgaa at rank #5,094 across all assignees tracked by PlainPatent. This portfolio spans 23 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.8 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, Merz Pharma Gmbh & Co. Kgaa is one of the more focused assignees in the PatentsView dataset. By volume, Merz sits between LVMH Recherche (68 patents, rank #5,090) and Ningbo University (68 patents, rank #5,098) - the closest US assignees by grant volume. The composite Innovation Score of 45.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 37 grants, compared with 31 in the 2015–2019 window, a +19% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Merz Pharma Gmbh & Co. Kgaa's 12.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 23 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Merz Pharma Gmbh & Co. Kgaa against peers pursuing similar technology classes.

LVMH Recherche

68
Maquet Cardiovasc…

68
Medizinische Hoch…

68
Medtronic Holding…

68
Middle Chart

68
Nelson Irrigation

68
Nutrition & Biosc…

68
Ningbo University

68
Merz Pharma & Kgaa ◀

68

What this shows Merz holds 68 patents at rank #5,094, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Merz

By rank, the assignees closest to #5,094 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Merz's primary technology class.

Merz's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

46 Top 23% higher than 77% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Merz Pharma Gmbh & Co. Kgaa patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	11	16.2%
2016	7	10.3%
2017	4	5.9%
2018	5	7.4%
2019	4	5.9%
2020	8	11.8%
2021	7	10.3%
2022	9	13.2%
2023	2	2.9%
2024	7	10.3%
2025	4	5.9%

Which technologies does Merz Pharma Gmbh & Co. Kgaa patent most?

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 46

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 33

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 32

C12Y - ENZYMES 24

A61Q - SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS 24

C07K - PEPTIDES 21

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 17

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 12

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 9

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 8

C08B - POLYSACCHARIDES; DERIVATIVES THEREOF 7

C08L - COMPOSITIONS OF MACROMOLECULAR COMPOUNDS 6

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 4

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 3

B32B - LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM 2

Top 15 of 23 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Growing

Where it ranks

Overall rank by patents

#5,094

Across all tracked assignees

Innovation Score

45.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Merz Pharma Gmbh & Co. Kgaa hold?

Merz Pharma Gmbh & Co. Kgaa holds 68 US granted patents filed between 2015 and 2025, spanning 23 technology areas.

What is Merz Pharma Gmbh & Co. Kgaa's Innovation Score?

Merz Pharma Gmbh & Co. Kgaa has an Innovation Score of 45.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Merz Pharma Gmbh & Co. Kgaa focus on?

Merz Pharma Gmbh & Co. Kgaa's top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 46 patents. The company has filed patents in 23 CPC subclasses total.

Is Merz Pharma Gmbh & Co. Kgaa's patent filing rate increasing or decreasing?

Merz Pharma Gmbh & Co. Kgaa's recent filing velocity is +19% compared to the prior five-year period. The company is maintaining or growing its patent output.

What does claim depth mean for Merz Pharma Gmbh & Co. Kgaa's patents?

Merz Pharma Gmbh & Co. Kgaa's patents average 12.8 claims each. This falls within the standard range, providing solid legal coverage.

How is the Merz Pharma Gmbh & Co. Kgaa patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Merz's 68 grants land it in the top 23% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Merz ranks #5,094 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.